WASHINGTON (Reuters) - A U.S. appeals court granted on Thursday an Obama administration request to temporarily lift a judge's ban on federal funding of research involving human embryonic stem cells.

WASHINGTON (Reuters) - A U.S. appeals court granted on Thursday an Obama administration request to temporarily lift a judge's ban on federal funding of research involving human embryonic stem cells.

WASHINGTON (Reuters) - A U.S. judge refused on Tuesday to lift a ban on federal funding of human embryonic stem cell research despite Obama administration warnings it would set back key research and cost more than a thousand jobs.

Bristol-Myers Squibb to buy ZymoGenetics for $885 million, or $9.75 per share in cash. Bristol-Myers Squibb Co. said Tuesday it will acquire biotechnology partner ZymoGenetics Inc. for $885 million in another move by a major drugmaker to boost its pipeline by snapping up a smaller developer.

Bristol-Myers Squibb Co. said Tuesday it will acquire biotechnology partner ZymoGenetics Inc. for $885 million in another move by a major drugmaker to boost its pipeline by snapping up a smaller developer.

Europe slapped a summons on German chemical giant BASF on Monday after a "blunder" allowed seed from a new genetically modified potato to remain in a field in Sweden.

Over 70 environmental NGOs including the WWF called Monday for the sacking of Romania's new agriculture minister for his links to the genetically modified crop industry.

US authorities have begun to consider approval for the first time the sale of genetically engineered salmon, a move that some say could open the door to more transgenic animals on American dinner tables.

Two groups of scientists have developed tests for gene doping in what the World Anti-Doping Agency hailed Friday as a major breakthrough in fighting the next frontier in cheating in sports.

Scientists devise tests for gene doping; experts call it 'major breakthrough'. Two groups of scientists have developed tests for gene doping in what the World Anti-Doping Agency hailed Friday as a major breakthrough in fighting the next frontier in cheating in sports.

A Chinese researcher has been arrested and charged with stealing trade secrets about insecticides from US biotech company Dow and passing them on to China, court documents showed Tuesday.

German chemical giant BASF said Tuesday it was seeking European Union approval for a new genetically modified potato six months after getting an EU green light for its Amflora spud.

WASHINGTON (Reuters) - U.S. health officials are set to rule on whether a faster-growing, genetically engineered fish is safe to eat in a decision that could deliver the first altered animal food to consumers' dinner plates.

WASHINGTON (Reuters) - U.S. health officials are set to rule on whether a faster-growing, genetically engineered fish is safe to eat in a decision that could deliver the first altered animal food to consumers' dinner plates.

BRUSSELS (Reuters) - The Canadian government has voiced concerns about a European Union proposal to allow member states to decide whether to ban genetically modified (GM) crops.

Bunge CFO Fouse to depart Sept. 24 for Celgene Corp.. Bunge Ltd., an international agribusiness and food company, said Thursday its chief financial officer plans to leave for another company.

Mass. reaches $1.35M settlement with biotech company Stryker over product marketing. Massachusetts officials say a biotech company has agreed to pay $1.35 million to resolve allegations that it marketed medical products for purposes that had not been approved by regulators.

British scientists have grown liver cells out of stem cells from human skin, boosting hopes that healthy cells can be transplanted into organs to repair damage from diseases like cirrhosis and cancer, according to new findings.

British scientists have grown liver cells out of stem cells from human skin, boosting hopes that healthy cells can be transplanted into organs to repair damage from diseases like cirrhosis and cancer, according to new findings.

A judge's ruling halting planting of genetically modified sugar beet seeds has left some U.S. growers feeling uncertain as they wait for federal officials to decide the next step for a crop that provides half of America's sugar supply.